US Stock MarketDetailed Quotes
IBRX ImmunityBio
- 6.420
- -0.190-2.87%
Close May 31 16:00 ET
- 6.450
- +0.030+0.47%
Post 19:57 ET
4.44BMarket Cap-5944P/E (TTM)
7.000High6.390Low3.86MVolume6.610Open6.610Pre Close25.41MTurnover2.41%Turnover RatioLossP/E (Static)691.57MShares10.53052wk High-6.41P/B1.03BFloat Cap1.25052wk Low--Dividend TTM160.49MShs Float45.420Historical High--Div YieldTTM9.23%Amplitude0.930Historical Low6.574Avg Price1Lot Size
ImmunityBio Key Stats
Quarterly+Annual
YOY
| (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -88.89%40K | 159.17%622K | 90.41%139K | -30.51%82K | 17.14%41K | 2,471.43%360K | -74.30%240K | -81.28%73K | 78.79%118K | -89.68%35K |
| Operating revenue | -88.89%40K | 159.17%622K | 90.41%139K | -30.51%82K | 17.14%41K | 2,471.43%360K | -74.30%240K | -81.28%73K | 78.79%118K | -89.68%35K |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | -14.92%95.24M | 3.17%361.99M | 0.42%84.64M | -11.77%80.22M | 6.94%85.19M | 16.62%111.94M | 5.93%350.86M | 5.81%84.29M | 15.23%90.92M | -7.64%79.66M |
| Selling and administrative expenses | 28.18%41.89M | 26.20%129.62M | 26.30%33.11M | 64.76%31.82M | 93.17%32.02M | -19.53%32.68M | -24.06%102.71M | -6.08%26.22M | -34.82%19.31M | -48.91%16.58M |
| Research and development costs | -32.69%53.35M | -6.36%232.37M | -11.27%51.53M | -32.41%48.4M | -15.72%53.17M | 43.13%79.26M | 26.63%248.15M | 12.22%58.08M | 45.33%71.61M | 17.25%63.08M |
| Operating profit | 14.68%-95.2M | -3.07%-361.36M | -0.34%-84.5M | 11.75%-80.14M | -6.94%-85.15M | -16.26%-111.58M | -6.16%-350.62M | -6.24%-84.22M | -15.18%-90.8M | 7.31%-79.62M |
| Net non-operating interest income expense | -26.40%-37.33M | -111.05%-128.34M | -16.76%-32.75M | -108.41%-34.41M | -249.49%-31.64M | -310.45%-29.53M | -333.93%-60.81M | -566.83%-28.05M | -370.00%-16.51M | -161.30%-9.05M |
| Non-operating interest income | -43.66%160K | -68.13%863K | -220.97%-623K | 141.11%610K | -8.07%592K | -78.09%284K | 223.92%2.71M | 81.34%515K | 150.50%253K | 475.00%644K |
| Non-operating interest expense | 25.73%37.49M | 103.41%129.2M | 12.48%32.13M | 108.91%35.02M | 232.39%32.24M | 251.98%29.82M | 327.74%63.52M | 536.12%28.56M | 363.86%16.76M | 171.12%9.7M |
| Other net income (expense) | -106.55%-1.61M | -1,506.84%-94.19M | -3,024.06%-116.2M | 591.55%18.91M | -247.86%-21.43M | 14,414.20%24.53M | -5.70%-5.86M | 149.23%3.97M | 36.74%-3.85M | -51,225.00%-6.16M |
| Gain on sale of security | -113.91%-3.85M | -637.56%-49.18M | -980.14%-80.14M | 2,129.64%13.69M | -423.22%-10.41M | 1,850.88%27.68M | 305.67%9.15M | 230.00%9.11M | 110.22%614K | -648.12%-1.99M |
| Earnings from equity interest | --0 | 37.65%-7.55M | --0 | 71.84%-1.26M | -1.46%-3.96M | -1,086.29%-2.34M | -1,407.72%-12.11M | -342.59%-3.55M | ---4.46M | ---3.9M |
| Special income (charges) | ---- | -30.10%-886K | ---- | ---- | ---- | ---- | ---681K | ---- | ---- | ---- |
| -Less:Impairment of capital assets | ---- | 30.10%886K | ---- | ---- | ---- | ---- | --681K | ---- | ---- | ---- |
| Other non- operating income (expenses) | 98.14%-20K | -5,120.92%-38.43M | -3,911.16%-37.02M | 107,733.33%6.47M | -3,773.51%-6.8M | -26,825.00%-1.08M | -481.35%-736K | -1,464.41%-923K | 115.79%6K | -33.21%185K |
| Income before tax | -15.05%-134.13M | -39.93%-583.89M | -115.58%-233.45M | 13.96%-95.64M | -45.74%-138.21M | -13.19%-116.58M | -19.28%-417.29M | -18.28%-108.29M | -25.71%-111.16M | -6.10%-94.84M |
| Income tax | 0 | -217.65%-40K | -217.65%-40K | 0 | 0 | 0 | 277.78%34K | 3,300.00%34K | 0 | 0 |
| Net income | -15.05%-134.13M | -39.91%-583.85M | -115.47%-233.41M | 13.96%-95.64M | -45.74%-138.21M | -13.19%-116.58M | -19.29%-417.32M | -18.32%-108.33M | -25.71%-111.16M | -6.10%-94.84M |
| Net income continuous Operations | -15.05%-134.13M | -39.91%-583.85M | -115.47%-233.41M | 13.96%-95.64M | -45.74%-138.21M | -13.19%-116.58M | -19.29%-417.32M | -18.32%-108.33M | -25.71%-111.16M | -6.10%-94.84M |
| Minority interest income | 91.25%-21K | 12.88%-656K | 80.18%-22K | 73.09%-60K | -35.22%-334K | -39.53%-240K | 75.38%-753K | 62.24%-111K | 72.13%-223K | 77.48%-247K |
| Net income attributable to the parent company | -15.27%-134.11M | -40.00%-583.2M | -115.67%-233.39M | 13.84%-95.58M | -45.77%-137.88M | -13.15%-116.34M | -20.12%-416.57M | -18.58%-108.22M | -26.60%-110.94M | -7.14%-94.59M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | -15.27%-134.11M | -40.00%-583.2M | -115.67%-233.39M | 13.84%-95.58M | -45.77%-137.88M | -13.15%-116.34M | -20.12%-416.57M | -18.58%-108.22M | -26.60%-110.94M | -7.14%-94.59M |
| Basic earnings per share | 25.93%-0.2 | -10.58%-1.15 | -40.74%-0.38 | 32.14%-0.19 | -33.33%-0.32 | -3.85%-0.27 | -16.85%-1.04 | -17.39%-0.27 | -27.27%-0.28 | -4.35%-0.24 |
| Diluted earnings per share | 25.93%-0.2 | -10.58%-1.15 | -40.74%-0.38 | 32.14%-0.19 | -33.33%-0.32 | -3.85%-0.27 | -16.85%-1.04 | -17.39%-0.27 | -27.27%-0.28 | -4.35%-0.24 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg